I agree that this site is using cookies. You can find further informations here.
X
Miltényi, Z.
8  results:
Search for persons X
?
1

PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN M..:

Miltényi, Z. ; Dr Gál, A. E. ; Tóthfalusi, D..
HemaSphere.  6 (2022)  - p. 1803-1804 , 2022
Link: https://doi.org/10.1097/..
 
?
2

IMPACT OF AUTOIMMUNE CYTOPENIAS ON THE CLINICAL COURSE AND ..:

Pinczés, L.I. ; Szabó, R. ; Miltényi, Z..
Hematological Oncology.  37 (2019)  S2 - p. 499-499 , 2019
Link: https://doi.org/10.1002/..
 
?
3

PROGNOSTIC VALUE OF PRE‐TRANSPLANT PET/CT IN HODGKIN LYMPHO..:

Miltényi, Z. ; Punk, E. ; Pinczés, L..
Hematological Oncology.  37 (2019)  S2 - p. 497-498 , 2019
Link: https://doi.org/10.1002/..
 
?
4

Combined prognostic value of absolute lymphocyte/monocyte r..:

Simon, Zsofia ; Barna, S. ; Miltenyi, Z....
International Journal of Hematology.  103 (2015)  1 - p. 63-69 , 2015
Link: https://doi.org/10.1007/..
 
?
5

PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN M..:

Miltényi, Z ; Dr Gál, A. E ; Tóthfalusi, D.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428984/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

PB1924: ARE WE TAKING ADVANTAGE OF THERAPEUTIC OPTIONS IN M..:

Z. Miltényi ; A. E. Dr Gál ; D. Tóthfalusi.
http://journals.lww.com/10.1097/01.HS9.0000850548.60681.40.  , 2022
Link: https://doi.org/10.1097/..
 
?
7

Oligomeganephronic Renal Hypoplasia:

Detre, Z. ; Miltényi, M.
Pathology - Research and Practice.  178 (1984)  4 - p. 416-418 , 1984
Link: https://doi.org/10.1016/..
 
?
8

Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune res..:

Loyal, L ; Braun, J ; Henze, L...
http://edoc.mdc-berlin.de/20900/1/20900oa.pdf.  , 2021
Link: http://edoc.mdc-berlin.d..
 
1-8